Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. (Q41654654)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kamran Zargar-Shoshtari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Jamie T Caracciolo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Mayer Fishman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Michael A Poch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Julio Pow-Sang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Wade J Sexton

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Philippe E Spiess

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

18 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

339.e17-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Definition and classification of cancer cachexia: an international consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Serum protein concentration and relative albumin percentage in normal individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Serum and urine albumin: a progress report on their measurement and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Response of hepatic proteins to the lowering of habitual dietary protein to the recommended safe level of intake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Effects of hypercaloric feeding on nutrition status and carbon dioxide production in patients with long-term mechanical ventilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Surrogate nutrition markers, malnutrition, and adequacy of nutrition support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2015.01.011

10.1016/J.UROLONC.2015.01.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26094169%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference